Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial

BACKGROUND: Short stature is the most consistent characteristic feature of Turner syndrome (TS). To improve final heights of children with TS effectively, it is important to provide them with early and appropriate treatment using growth hormone (GH). The objective of this study was to assess the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinsup, Kim, Min-Sun, Suh, Byung-Kyu, Ko, Cheol Woo, Lee, Kee-Hyoung, Yoo, Han-Wook, Shin, Choong Ho, Hwang, Jin Soon, Kim, Ho-Seong, Chung, Woo Yeong, Kim, Chan Jong, Han, Heon-Seok, Jin, Dong-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662840/
https://www.ncbi.nlm.nih.gov/pubmed/34893062
http://dx.doi.org/10.1186/s12902-021-00904-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662840/
https://www.ncbi.nlm.nih.gov/pubmed/34893062
http://dx.doi.org/10.1186/s12902-021-00904-5

Ejemplares similares